Fonte: Current Diabetes Reports. Unidade: FMRP
Assuntos: AUTOIMUNIDADE, DIABETES MELLITUS, TRANSPLANTES, CÉLULAS-TRONCO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COURI, Carlos Eduardo Barra e OLIVEIRA, Maria Carolina de e SIMÕES, Belinda Pinto. Risks, benefits, and therapeutic potential of hematopoietic stem cell transplantation for autoimmune diabetes. Current Diabetes Reports, v. 12, n. 5, p. 604-611, 2012Tradução . . Disponível em: https://doi.org/10.1007/s11892-012-0309-0. Acesso em: 02 nov. 2025.APA
Couri, C. E. B., Oliveira, M. C. de, & Simões, B. P. (2012). Risks, benefits, and therapeutic potential of hematopoietic stem cell transplantation for autoimmune diabetes. Current Diabetes Reports, 12( 5), 604-611. doi:10.1007/s11892-012-0309-0NLM
Couri CEB, Oliveira MC de, Simões BP. Risks, benefits, and therapeutic potential of hematopoietic stem cell transplantation for autoimmune diabetes [Internet]. Current Diabetes Reports. 2012 ; 12( 5): 604-611.[citado 2025 nov. 02 ] Available from: https://doi.org/10.1007/s11892-012-0309-0Vancouver
Couri CEB, Oliveira MC de, Simões BP. Risks, benefits, and therapeutic potential of hematopoietic stem cell transplantation for autoimmune diabetes [Internet]. Current Diabetes Reports. 2012 ; 12( 5): 604-611.[citado 2025 nov. 02 ] Available from: https://doi.org/10.1007/s11892-012-0309-0
